Preclinical animal experiments and cellular models have demonstrated that ET-1 could induce VEGF expression by increasing levels of hypoxia-inducible factor 1α (HIF-1α), which plays an important role in the development of kidney cancer 94. Here, EDN1 is linked to kidney cancer.